← Back to Search

Dietary Supplement

Saffron for Inflammatory Bowel Disease

N/A
Waitlist Available
Research Sponsored by Howard University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 8-12 weeks
Awards & highlights

Study Summary

This trial is testing whether saffron extract can help treat patients with colitis.

Eligible Conditions
  • Ulcerative Colitis

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~8-12 weeks
This trial's timeline: 3 weeks for screening, Varies for treatment, and 8-12 weeks for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
C reactive protein assessment
Serum Anti-inflammatory assessment
Serum Pro-inflammatory assessment
+6 more
Secondary outcome measures
endoscopy colitis assessment

Trial Design

3Treatment groups
Active Control
Placebo Group
Group I: Low dose saffronActive Control1 Intervention
healthy, mild-moderate ulcerative colitis for low dose
Group II: High dose SaffronActive Control1 Intervention
healthy, mild-moderate ulcerative colitis for high dose
Group III: PlaceboPlacebo Group1 Intervention
healthy, mild-moderate ulcerative colitis for placebo

Find a Location

Who is running the clinical trial?

Howard UniversityLead Sponsor
39 Previous Clinical Trials
13,147 Total Patients Enrolled
Hassan AshktorabStudy ChairHoward Uinversity

Media Library

Saffron Extract (Dietary Supplement) Clinical Trial Eligibility Overview. Trial Name: NCT04749576 — N/A
Ulcerative Colitis Research Study Groups: Low dose saffron, High dose Saffron, Placebo
Ulcerative Colitis Clinical Trial 2023: Saffron Extract Highlights & Side Effects. Trial Name: NCT04749576 — N/A
Saffron Extract (Dietary Supplement) 2023 Treatment Timeline for Medical Study. Trial Name: NCT04749576 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Might I qualify for participation in this investigation?

"This clinical trial is recruiting 100 individuals with ulcerative colitis, aged 18 to 80. To be eligible, applicants should meet the following criteria: Possess a UC diagnosis that has been confirmed via endoscopy and histology at least 3 months prior., Be male or female older than eighteen years of age., Have not previously received treatment for their condition., Those who have already undergone traditional treatments but lack sufficient improvement may also apply if they are willing to take saffron in addition.. Additionally, those who haven't benefited from available interventions can opt instead for saffron as an alternative therapy choice."

Answered by AI

How many participants are accepted into this study?

"Affirmative. According to clinicaltrials.gov, the study is currently in search of participants; it was posted on December 15th 2020 and was updated as recently as February 8th 2021. A total of 100 volunteers are required for this research at a single medical centre."

Answered by AI

Does this experiment adhere to the criterion of patients aged 65 years or over?

"The requirements to take part in this clinical trial are that patients must be between 18 and 80 years old. There are separate studies for those below the age of consent, as well as a separate cohort of 254 above the retirement age."

Answered by AI

Is there an ongoing recruitment of participants for this experiment?

"According to the clinicaltrials.gov repository, this study is still recruiting participants since its initial posting on December 15th 2020 and last update on February 8th 2021."

Answered by AI
~23 spots leftby Apr 2025